Moreover, TIGIT expression has been found to positively correlate with PD-1 and PD-L1 density in the tumor microenvironment (TME), highlighting the synergy between the two immune-checkpoint axes, as seen in lung squamous cell carcinoma, lung adenocarcinoma, and melanoma [35,36,37]. This evidence concerns the gene TIGIT and neoplasm.